Polyclonal B-cell lymphocytosis mimicking malignant lymphoma in a newborn

Kit Fai Wong1, Hui Leung Yuen, Jennifer N S Leung

  • 1Department of Pathology, Queen Elizabeth Hospital, Hong Kong SAR, China. kfwong@ha.org.hk <kfwong@ha.org.hk>

Insights

A newborn experienced fever and unusual lymphocytes, initially suspected as lymphoma. Further tests revealed a benign, self-limiting polyclonal lymphocytosis, resolving within a month.

Area of Science:

  • Pediatric Hematology
  • Immunology
  • Neonatal Medicine

Background:

  • Neonatal fever and lymphocytosis can mimic serious conditions like leukemia.
  • Distinguishing benign reactive lymphocytosis from malignancy is crucial in newborns.

Observation:

  • A 17-day-old infant presented with fever and atypical peripheral blood lymphocytes.
  • These lymphocytes exhibited large size, irregular nuclei, and immature features, raising concern for malignant lymphoma.
  • Initial presentation suggested a potential leukemic phase of lymphoma.

Findings:

  • Immunophenotyping identified the lymphocytes as CD19-positive B cells expressing both kappa and lambda light chains.
  • Molecular studies confirmed a polyclonal immunoglobulin heavy-chain gene rearrangement, indicating a non-clonal origin.
  • Cytogenetic analysis revealed a normal karyotype, and infectious workup was negative.

Implications:

  • This case highlights the importance of comprehensive immunophenotypic and molecular analysis in diagnosing neonatal lymphocytosis.
  • It demonstrates that unusual lymphocyte morphology in neonates can represent a benign, self-limiting condition.
  • Accurate diagnosis prevents unnecessary aggressive treatment for conditions like lymphoma.

Related Concept Videos

Hybridoma Technology01:31

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...